Journal of radiation oncology最新文献_第9页

In memoriam: the legendary Dr. Luther Brady—founding ACRO president and founding JRO editor in chief 纪念:传奇的路德·布雷迪博士——ACRO的创始主席和JRO的创始主编

Journal of radiation oncology Pub Date : 2018-09-01 DOI: 10.1007/s13566-018-0360-9

B. Teh, J. Welsh, Jiade J. Lu

引用次数: 0

Comparison of ICRU 38 rectal reference point dose estimates with measured dose in vivo in cobalt-60 HDR brachytherapy for cervical cancer ICRU 38直肠参考点剂量估计值与体内测量剂量在钴-60 HDR近距离治疗宫颈癌中的比较

Journal of radiation oncology Pub Date : 2018-08-18 DOI: 10.1007/s13566-020-00420-4

C. V. Villafuerte, E.J.J. Fragante, Marivic Bacaling Candado

引用次数: 0

A phase II trial to determine the cosmetic outcomes and toxicity of 27 Gy in five-fraction accelerated partial breast irradiation: the ACCEL trial 一项II期试验，旨在确定27 Gy五段式加速部分乳房照射的美容效果和毒性:ACCEL试验

Journal of radiation oncology Pub Date : 2018-08-02 DOI: 10.1007/s13566-018-0359-2

P. Grendarova, S. Quirk, M. Roumeliotis, M. Lesiuk, T. Austin, Katelyn Bignell, Hong-wei Liu, P. Craighead, Jane Wilson, T. Phan, I. Olivotto

引用次数: 9

A fiducial-less tracking method for radiation therapy of liver tumors by diaphragm disparity analysis part 1: simulation study using machine learning through artificial neural network 一种基于横膈膜视差分析的肝肿瘤放射治疗无基准跟踪方法。第一部分:通过人工神经网络进行机器学习的仿真研究

Journal of radiation oncology Pub Date : 2018-07-24 DOI: 10.1007/s13566-018-0358-3

D. Dick, Xiaodong Wu, G. Hatoum, Weizhao Zhao

引用次数: 5

Reducing radiation dermatitis during ongoing radiation therapy: an innovative film-forming wound dressing 在持续的放射治疗中减少放射性皮炎:一种创新的成膜伤口敷料

Journal of radiation oncology Pub Date : 2018-07-20 DOI: 10.1007/s13566-018-0356-5

A. Quilis, J. Martin, Concepción Rodríguez, Purificación Sánchez, J. L. Ribes

引用次数: 8

The effects of treatment duration on outcomes of radiation treatment with high-dose-rate brachytherapy in the era of concurrent chemoradiation for cervical carcinoma 同步放化疗时代宫颈癌放疗时间对高剂量率近距离放疗疗效的影响

Journal of radiation oncology Pub Date : 2018-07-17 DOI: 10.1007/s13566-018-0357-4

T. W. Chen, N. Wandrey, C. Ha, T. Eng

引用次数: 0

Musculoskeletal outcomes and the effect of radiation to the vertebral bodies on growth trajectories for long-term survivors of high-risk neuroblastoma. 高危神经母细胞瘤长期幸存者的肌肉骨骼预后和椎体辐射对生长轨迹的影响。

Journal of radiation oncology Pub Date : 2018-06-01 Epub Date: 2018-03-29 DOI: 10.1007/s13566-018-0349-4

Matthew J Ferris, Sibo Tian, Jeffrey M Switchenko, Nicholas A Madden, Bree R Eaton, Natia Esiashvili

{"title":"Musculoskeletal outcomes and the effect of radiation to the vertebral bodies on growth trajectories for long-term survivors of high-risk neuroblastoma.","authors":"Matthew J Ferris, Sibo Tian, Jeffrey M Switchenko, Nicholas A Madden, Bree R Eaton, Natia Esiashvili","doi":"10.1007/s13566-018-0349-4","DOIUrl":"https://doi.org/10.1007/s13566-018-0349-4","url":null,"abstract":"Objective: Here, we report musculoskeletal outcomes and the impact of radiotherapy dose on vertebral body growth for an institutional series of long-term survivors of high-risk neuroblastoma.Methods: We conducted a retrospective study of 23 patients who were disease-free and at least 36 months from the end of treatment. The patients were initially treated from July 2003 to May 2012. Patient records were reviewed for growth percentiles (obtained at approximately 6-month intervals from onset of treatment to the last follow-up) and musculoskeletal comorbidities. RT plans and most recent surveillance CT scans were reviewed for locations of in-field vertebral bodies and corresponding vertebral growth patterns.Results: The median follow-up was 7.93 years. The median prescribed radiation dose was 21.6 Gy. Musculoskeletal abnormalities included scoliosis (5 patients), muscular hypoplasia (3), and hypodontia (1). The median growth percentile at treatment onset was 35.5 (range, 4.7-100) versus 10 (0-94.1) at the last follow-up. The median numbers of vertebral bodies encompassed (by at least half of their volume) by the 5-, 10-, 15-, and 20-Gy isodose lines were 7 (mean, 6.78), 7 (6.56), 6 (6.17), and 6 (5.52), respectively. Sixteen patients (70.0%) had in-field abnormalities in vertebral body growth, manifesting as stretches of successive vertebral bodies at the same height, while normally there is a gradual vertebral body height increase progressing caudally down the spinal column.Conclusions: Musculoskeletal abnormalities, below average height, and stunted in-field vertebral body growth are routine in long-term survivors of high-risk neuroblastoma. Sparing vertebral bodies when feasible may lead to improvement in patient growth trajectories.","PeriodicalId":89815,"journal":{"name":"Journal of radiation oncology","volume":"7 2","pages":"187-193"},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13566-018-0349-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39113205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy. 放射治疗肿瘤组94-10的经济分析:同步放化疗与顺序放化疗的成本-效果。

Journal of radiation oncology Pub Date : 2018-06-01 Epub Date: 2018-03-10 DOI: 10.1007/s13566-018-0346-7

Andre Konski, Mytheryi Bhargavan, Jean Owen, Ritsuko Komaki, Corey J Langer, Elizabeth Gore, Rebecca Paulus, Hak Choy, Deborah-Watkins Bruner, Walter J Curran

{"title":"An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy.","authors":"Andre Konski, Mytheryi Bhargavan, Jean Owen, Ritsuko Komaki, Corey J Langer, Elizabeth Gore, Rebecca Paulus, Hak Choy, Deborah-Watkins Bruner, Walter J Curran","doi":"10.1007/s13566-018-0346-7","DOIUrl":"https://doi.org/10.1007/s13566-018-0346-7","url":null,"abstract":"Background: Cost can be a major issue in therapeutic decision-making, and in particular for patients with locally advanced non-small cell lung cancer (LA-NSCLC).Methods: The specific aim of this analysis was to evaluate the costs and outcomes of patients treated on Radiation Therapy Oncology Group (RTOG) 94-10, Medicare Part A and Part B costs from all for patients treated from 1991 to 1996 on RTOG 94-10, a phase III trial showing a survival benefit for concurrent chemoradiation (STD RT) over sequential (RT day 50) chemoradiation in LA-NSCLC with intermediate outcome for concurrent twice daily radiation and chemotherapy (HFX RT). 26-month expected costs for each arm of the trial in 1996 dollars were determined, with Kaplan Meier sampling average estimates of survival probabilities for each month and mean monthly costs. The analysis was performed from a payer's perspective. Incremental cost-effectiveness ratios were calculated comparing RT on day 50 and HFX RT to the STD RT.Results: Of the 610 patients entered, Medicare cost data and clinical outcomes were available for 92 patients. In this subset, compared to STD RT, RT on day 50 proved less costly but resulted in reduced survival at 1 year. In addition, HFX RT cost slightly more than STD RT but was less effective in this cohort of patients.Conclusions: In patients with Medicare insurance and with significant toxicity burden, RT on day 50 is the least expensive but also least effective treatment in this subset of patients treated on RTOG 94-10.","PeriodicalId":89815,"journal":{"name":"Journal of radiation oncology","volume":"7 2","pages":"195-201"},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13566-018-0346-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36781538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Image-guided adaptive radiotherapy improves acute toxicity during intensity-modulated radiation therapy for head and neck cancer 图像引导的适应性放疗可改善头颈癌调强放疗期间的急性毒性

Journal of radiation oncology Pub Date : 2018-06-01 DOI: 10.1007/s13566-017-0336-1

A. Chen, T. Yoshizaki, Sophia Hsu, Argin G. Mikaeilian, M. Cao

引用次数: 8

Re-irradiation in gynecological cancers, present experiences and future hopes 妇科癌症的再照射，目前的经验和未来的希望

Journal of radiation oncology Pub Date : 2018-05-19 DOI: 10.1007/s13566-018-0355-6

Susovan Banerjee, S. Goyal, T. Kataria, D. Gupta, K. Patro, Abhidha Malik, S. Bisht, A. Abhishek

引用次数: 5